Traitement national des entreprises sous contrôle étranger

Le "Traitement national" est l'engagement pris par les pays adhérent à la Déclaration sur l'Investissement international et les entreprises multinationales de traiter les entreprises opérant sur leur territoire mais sous le contrôle de ressortissants d'un autre pays membre non moins favorablement que les entreprises nationales dans les mêmes circonstances.

Also Available

• National Treatment for Foreign-Controlled Enterprises

La Déclaration de l'OCDE et les Décisions sur l'investissement international et les entreprises multinationales

La Déclaration de 1976 constitue un engagement au niveau politique par les gouvernements des pays membres et adhérents à améliorer le climat des investissements étrangers, favoriser la contribution positive que les entreprises multinationales peuvent apporter au progrès économique et social, et permettre de réduire au minimum et de résoudre les difficultés qui peuvent résulter de leurs diverses opérations.

Also Available

• OECD Declaration and Decisions on International Investment and Multinational Enterprises

Traitement national des entreprises sous contrôle étranger : Liste des mesures notifiées par pays au titre de la transparence

Les signataires de la Déclaration de l’OCDE sur l'investissement international et les entreprises multinationales s’engagent à informer l’Organisation de toutes les mesures qui ont un effet sur le traitement national. Le présent rapport publie les listes par pays des mesures autres que les « exceptions au traitement national » notifiées à des fins de transparence.

Related Documents

• L'Instrument relatif au Traitement national

Also Available

Malaysia - OECD Investment Policy Review

The Malaysian government, in partnership with the OECD and ASEAN, has undertaken a review of its investment policies as part of an active programme of investment policy reforms to help revive both foreign and domestic investment.

Conference on advancing responsible business practices in the Asia-Pacific region

Jointly organised by the OECD and ESCAP, this conference focused on the role of governments in supporting and facilitating more sustainable and inclusive business practices in the Asia-Pacific region.

Forum on implementing due diligence for responsible mineral supply chains

Participants in this multi-stakeholder meeting reviewed and discussed the implementation of the OECD Due Diligence Guidance and in the 3Ts supply chain to ensure that companies avoid contributing to conflict through their mineral or metal purchasing decisions and practices.

Mozambique - OECD Investment Policy Review

This Investment Policy Review examines Mozambique's achievements in developing an open and transparent investment regime and its efforts to reduce restrictions on international investment.

Also Available

• Tanzania - OECD Investment Policy Review

Investment treaties as corporate law: Shareholder claims and issues of consistency, International Investment Working Paper 2103/3

Many investor-state dispute settlement (ISDS) claims are by shareholders for so-called "reflective loss" incurred as a result of injury to “their” company. This paper (i) compares the wide acceptance of such claims in ISDS with their general prohibition in advanced systems of national corporate law; and (ii) analyses policy issues raised by such claims (e.g., risk of double recovery, high legal costs, injury to creditors, etc.).

Policy impediments to infrastructure investment in Southern Africa

This OECD report to the G20 sheds light on reforms by which governments in Southern Africa can manage and accelerate the shift towards greater private participation in infrastructure. It draws on lessons learned from investment policy reviews in countries from the Southern African Development Community.

Inventory of investment measures taken between 16 February and 15 September 2013

This is a consolidated report covering investment measures taken between 15 February 2008 and 15 February 2013. The present report was prepared for the Freedom of Investment Roundtable 19 held on 15 October 2013.